Viridian Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 06/08/2026 | Sep 2025Filed 05/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 06/08/2026 | Sep 2024Filed 05/11/2025 | Jun 2024Filed 05/11/2025 | Mar 2024Filed 05/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $0.3 | $0.1 | $71 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | |
| −$127 | −$105 | −$35 | −$101 | −$87 | −$77 | −$65 | −$49 | |
| — | — | — | — | — | −$1.15 | −$1.02 | −$0.79 | |
| — | — | — | 82 | 81 | 66 | 64 | 61 |
Trend